Incidence and Occurrence of Total (First-Ever and Recurrent) Stroke

G. Rhys Williams, John Jiang, David B. Matchar, +1

Stroke

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study

Ciarán P. Kelly, P. H. R. Green, Joseph A. Murray, +10

Alimentary Pharmacology & Therapeutics

A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Laurence L. Greenhill, Joseph Biederman, Samuel W. Boellner, +5

Journal of the American Academy of Child & Adolescent Psychiatry

AdhdPsychiatryMedicinePsychotropic MedicationPediatrics +9

Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study

Joseph Biederman, James M. Swanson, Sharon B. Wigal, +5

PEDIATRICS

Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

James M. Swanson, Laurence L. Greenhill, Frank A. López, +4

The Journal of Clinical Psychiatry

Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate

Mona Darwish, Mary Kirby, Philmore Robertson, +2

The Journal of Clinical Pharmacology

Fentanyl Buccal TabletMedicinal ChemistryPharmaceutical SciencePharmacological StudyMedicine +11

Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers

Mona Darwish, Mary Kirby, Philmore Robertson, +2

Clinical Therapeutics

Healthy Adult VolunteersPharmacological StudyMedicinePharmacotherapyPain Management +6

Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics

Mona Darwish, Mary Kirby, Philmore Robertson, +2

Clinical Pharmacokinetics

MedicineFentanyl Buccal TabletsEquivalent DosesPharmacotherapyPharmacology +4

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1

Susanna A. McColley, Michael W. Konstan, Bonnie W. Ramsey, +8

Journal of Cystic Fibrosis

Translational MedicineAdvanced Lung DiseasePulmonary ExacerbationsPulmonary PharmacologyPulmonary Medicine +4

Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain

Mark Palangio, Michael Damask, Elena Morris, +4

Clinical Therapeutics

Pain TherapyPain ResearchHealth SciencesAcute PainPain Medicine +8